Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
8,6 USD | +1,18% | +2,02% | +9,14% |
27/03 | Les actions d'Outlook Therapeutics augmentent après le relèvement de la note de BTIG | MT |
27/03 | OUTLOOK THERAPEUTICS, INC. : BTIG réajuste son opinion à la hausse | ZM |
Métier
Nombre d'employés: 24
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
C. Trenary
CEO | Chief Executive Officer | 66 | 07/07/21 |
Lawrence Kenyon
DFI | Director of Finance/CFO | 58 | 15/09/15 |
Surendra Sharma
CTO | Chief Tech/Sci/R&D Officer | - | 19/01/23 |
Terry Dagnon
COO | Chief Operating Officer | 62 | 01/11/18 |
Alicia Tozier
SAM | Sales & Marketing | - | 02/03/22 |
Joel Prieve
PRN | Corporate Officer/Principal | - | 08/02/22 |
Jeff Evanson
PRN | Corporate Officer/Principal | 55 | 01/11/18 |
Jennifer Kissner
PRN | Corporate Officer/Principal | - | 26/04/19 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Randy Thurman
CHM | Chairman | 74 | 13/04/18 |
Kurt Hilzinger
BRD | Director/Board Member | 63 | 11/12/15 |
C. Trenary
CEO | Chief Executive Officer | 66 | 07/07/21 |
Lawrence Kenyon
DFI | Director of Finance/CFO | 58 | 15/09/15 |
Yazan Haddadin
BRD | Director/Board Member | 48 | 31/10/17 |
Julian Gangolli
BRD | Director/Board Member | 66 | 20/04/20 |
Gerd Auffarth
BRD | Director/Board Member | 59 | 20/04/20 |
Julia Haller
BRD | Director/Board Member | 69 | 11/08/22 |
Director/Board Member | 39 | 11/09/17 | |
Andong Huang
BRD | Director/Board Member | 27 | 19/06/20 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 22 298 542 | 13 636 212 ( 61,15 %) | 0 | 61,15 % |
Coordonnées société
Outlook Therapeutics, Inc.
485 Route 1 South Building F, Suite 320
08852, Iselin
+609 619 3990
http://www.outlooktherapeutics.comSecteur
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
+9,14% | 200 M | |
+25,69% | 47,86 Md | |
+46,90% | 41,42 Md | |
-3,46% | 40,66 Md | |
-6,20% | 28,92 Md | |
+9,17% | 25,55 Md | |
-20,42% | 19,27 Md | |
+28,07% | 12,14 Md | |
+0,17% | 12,15 Md | |
-1,24% | 11,99 Md |
- Bourse
- Actions
- Action OTLK
- Société Outlook Therapeutics, Inc.